IL6 and metabolic syndrome: There is, however, compelling evidence that MetS is associated with chronic low-grade inflammation, typically demonstrated by increased levels of C-reactive protein (CRP) and pro-inflammatory cytokines like interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα) compared to subjects without MetS [5, 6].